P

Inventor

LOW JONATHAN D

US22 patents
⚠️ This page may combine multiple inventors who share the name “LOW JONATHAN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

21 patents
US10640504B2May 5, 2020

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC50 citations97
US11306087B2Apr 19, 2022

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC16 citations94
US11090304B2Aug 17, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC33 citations94
US9611261B2Apr 4, 2017

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC25 citations94
US9085576B2Jul 21, 2015

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC31 citations94
US12083121B2Sep 10, 2024

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC7 citations85
US11993597B2May 28, 2024

Inhibitors of KRAS G12C and methods of using the same

AMGEN INC8 citations85
US11766436B2Sep 26, 2023

KRAS G12C inhibitors and methods of using the same

AMGEN INC11 citations85
US11285156B2Mar 29, 2022

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC16 citations85
US10632128B2Apr 28, 2020

Compounds that inhibit Mcl-1 protein

AMGEN INC5 citations83
US9593129B2Mar 14, 2017

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

AMGEN INC5 citations83
US9296736B2Mar 29, 2016

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

AMGEN INC7 citations83
US9012446B2Apr 21, 2015

Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use

AMGEN INC4 citations72
US12440491B2Oct 14, 2025

KRAS G12C inhibitors and methods of using the same

AMGEN INC1 citations64
US9296734B2Mar 29, 2016

Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC2 citations62
US11224601B1Jan 18, 2022

Compounds that inhibits MCL-1 protein

AMGEN INC0 citations61
US11279712B2Mar 22, 2022

Macrocyclic compounds that inhibit MCL-1 protein

AMGEN INC0 citations51
US10821115B2Nov 3, 2020

Compounds that inhibit Mcl-1 protein

AMGEN INC0 citations51
US9550762B2Jan 24, 2017

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC1 citations51
US10889581B2Jan 12, 2021

Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use

AMGEN INC0 citations47
US12473289B2Nov 18, 2025

Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use

AMGEN INC0 citations46

MINATTI ANA ELENA

1 patent